Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiji Ueda

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Nephrology (Carlton, Vic.)|November 13, 2007
Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney diseaseSeiji Ueda, Sho-Ichi Yamagishi, Yusuke Kaida, et al.
Current Drug Targets|August 21, 2007
Molecular mechanisms of diabetic nephropathy and its therapeutic interventionSho-ichi Yamagishi, Kei Fukami, Seiji Ueda, et al.
Current Pharmaceutical Design|July 13, 2013
Role of asymmetric dimethylarginine in cardiorenal syndromeSeiji Ueda, Sho-Ichi Yamagishi, Miyuki Yokoro, et al.
Cytotechnology|November 13, 2008
Establishment of Periodontal Ligament Cell Lines from Temperature-Sensitive Simian Virus 40 Large T-antigen Transgenic RatsMamoru Kubota, Mirei Chiba, Masuo Obinata, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 16, 2008
[Endothelial injury and CKD]Seiji Ueda, Yuriko Matsumoto, Yusuke Kaida, et al.
Current Drug Metabolism|March 12, 2009
Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disordersSho-ichi Yamagishi, Takanori Matsui, Seiji Ueda, et al.
Current Pharmaceutical Design|May 14, 2008
Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathySho-ichi Yamagishi, Seiji Ueda, Takanori Matsui, et al.
Cell and Tissue Research|April 23, 2005
Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDFSho-Ichi Yamagishi, Kazuo Nakamura, Seiji Ueda, et al.
Clinical and Experimental Nephrology|June 27, 2007
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney diseaseSeiji Ueda, Sho-Ichi Yamagishi, Yuriko Matsumoto, et al.
Cardiovascular Diabetology|March 15, 2014
Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expressionYuji Ishibashi, Takanori Matsui, Seiji Ueda, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Nephrology (Carlton, Vic.)|November 13, 2007
Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney diseaseSeiji Ueda, Sho-Ichi Yamagishi, Yusuke Kaida, et al.
Current Drug Targets|August 21, 2007
Molecular mechanisms of diabetic nephropathy and its therapeutic interventionSho-ichi Yamagishi, Kei Fukami, Seiji Ueda, et al.
Current Pharmaceutical Design|July 13, 2013
Role of asymmetric dimethylarginine in cardiorenal syndromeSeiji Ueda, Sho-Ichi Yamagishi, Miyuki Yokoro, et al.
Cytotechnology|November 13, 2008
Establishment of Periodontal Ligament Cell Lines from Temperature-Sensitive Simian Virus 40 Large T-antigen Transgenic RatsMamoru Kubota, Mirei Chiba, Masuo Obinata, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 16, 2008
[Endothelial injury and CKD]Seiji Ueda, Yuriko Matsumoto, Yusuke Kaida, et al.
Current Drug Metabolism|March 12, 2009
Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disordersSho-ichi Yamagishi, Takanori Matsui, Seiji Ueda, et al.
Current Pharmaceutical Design|May 14, 2008
Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathySho-ichi Yamagishi, Seiji Ueda, Takanori Matsui, et al.
Cell and Tissue Research|April 23, 2005
Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDFSho-Ichi Yamagishi, Kazuo Nakamura, Seiji Ueda, et al.
Clinical and Experimental Nephrology|June 27, 2007
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney diseaseSeiji Ueda, Sho-Ichi Yamagishi, Yuriko Matsumoto, et al.
Cardiovascular Diabetology|March 15, 2014
Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expressionYuji Ishibashi, Takanori Matsui, Seiji Ueda, et al.
Pageof 13